Answer:
"A programmable pump should be used to deliver an initial dose of 120mg over 2hours with 10% if the dose given intravenously."
Explanation:Ischemic stroke is a type of stroke that is associated with the brain,it is usually caused by the blockage or blockages in the artery which supplies blood to the brain,when this is blockage occurs,the amount of blood flow into the brain is either reduced or stopped,this will in turn reduce or eliminate the flow of oxygen into the brain.
WHEN THE OXYGEN REACHING THE BRAIN IS MINIMIZED OR STOPPED,THE BRAIN WILL DIE.
Answer:
2ml
Explanation:
There are 25mg in every ml;
The patient requires 50mg;
We can use ratios:
1 : 25
x : 50
x/1 = 50/25
x = 2
Answer: Three for the top, three for the bottom, elbows tucked in, safe effective grip, and comfort zone tried my best!
Explanation:none
The first comparison of PROs with axi-cel, an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, to SOC as second-line treatment (Tx) in relapsed/refractory (R/R) LBCL in the pivotal Phase 3 ZUMA-7 project.
According to ZUMA-7, the first randomized, international, multicenter Phase 3 study comparing axi-cel to SOC in second-line R/R LBCL, axi-cel treatment results in a clinically significant improvement in QoL at D100 when compared to SOC as determined by many recognized PRO tools. In the SOC arm, in particular, score comparisons at later timepoints call for cautious interpretation because attrition brought on by EFS events may have selected participants with the greatest results. The statistics also point to a quicker return to pretreatment quality of life with axi-cel than with SOC. Treatment options for second-line R/R LBCL should be influenced by axi-better cel's clinical results and patient experience compared to SOC.
Learn more about ZUMA-7 here:-
brainly.com/question/23849777
#SPJ4
